Terminology Service for NFDI4Health
All terms in MESH
| Label | Id | Description |
|---|---|---|
| CPCA protein, Aspergillus niger | C104754 | |
| TAK 218 | C104755 | |
| tetrathionate hydrolase | C104756 | |
| sanfetrinem | C104757 | |
| HAX1 protein, human | C104759 | |
| 2-((benzyloxycarbonyl)amino)-1,3a,4,5,10,10a-hexahydro-4-(1-phenylmethyl-2-carboxyethyl)indolo(3,2-e)indolizine-3(2H)-one | C118213 | |
| Pyricularia grisea | D055685 | [The anamorphic form of the fungus MAGNAPORTHE GRISEA and the most important pathogen of rice worldwide. It causes rice blast which prevents maturation of the rice grains.] |
| Mitosporic Fungi | D003904 | [A large and heterogenous group of fungi whose common characteristic is the absence of a sexual state. Many of the pathogenic fungi in humans belong to this group.] |
| 3-(4-(aminoiminomethyl)phenyl)-5-((((2-carboxy-2-((3-methylphenyl)sulfonamido)ethyl)amino)carbonyl)methyl)-2-methylisoxazole | C118214 | |
| Metabolic Equivalent | D055686 | [A measurement of OXYGEN uptake in a sitting, resting person (resting oxygen consumption), varying with age, sex, race, and other factors. In normal adult men, one MET is approximately 3.5 ml O2/kg/min of body weight. Oxygen uptake during activities or work can be measured in METs which can be use to determine health status and exercise prescription.] |
| Oxygen Consumption | D010101 | [The rate at which oxygen is used by a tissue; microliters of oxygen STPD used per milligram of tissue per hour; the rate at which oxygen enters the blood from alveolar gas, equal in the steady state to the consumption of oxygen by tissue metabolism throughout the body. (Stedman, 25th ed, p346)] |
| Physical Examination | D010808 | [Systematic and thorough inspection of the patient for physical signs of disease or abnormality.] |
| 3-(4-(4-chlorophenyl)piperazinylmethyl)pyrazolo(1,5-a)pyridine | C118215 | |
| Musculoskeletal and Neural Physiological Phenomena | D055687 | [Properties, and processes of the MUSCULOSKELETAL SYSTEM and the NERVOUS SYSTEM or their parts.] |
| 1,5,6,7,8-pentahydro-5-hydroxy-1-ribofuranosyl-pyrimido(1,2-b)purine-4(4aH)-one | C118216 | |
| Digestive System and Oral Physiological Phenomena | D055688 | [Properties and processes of the DIGESTIVE SYSTEM and DENTITION as a whole or of any of its parts.] |
| 3'-chloro-5,7-dihydroxyisoflavone | C118217 | |
| LY 379268 | C118218 | |
| LY 389795 | C118219 | |
| Lelis Syndrome | C564261 |